MAKO-Uni-Knee Arthroplasty Clinical Outcomes and Function

NCT ID: NCT03354195

Last Updated: 2020-02-05

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 14 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2018-07-01
• Study Completion Date: 2020-01-30

Brief Summary

This study represents a single-surgeon/institution, non-randomized, consecutive series, prospective and comparative cohort design. The Principal Investigator is anticipating 100 study patients in the INTACT group and 35 patients in the Anterior Cruciate Ligament-Deficient group.The schedule of events lists the imaging procedures and questionnaires to be completed at each visit.

Subjects will be consented and enrolled within 28 days prior to surgery and participate in follow-up visits for two years following their Unicompartmental Knee Arthroplasty. A 3-year enrollment duration is anticipated to enroll a minimum and consecutive series of 25 patients in the experimental Anterior Cruciate Ligament-deficient group. Over the same enrollment duration, 100+ patients with intact Anterior Cruciate Ligaments are expected to be in the control group and undergo Unicompartmental Knee Arthroplasty. The enrollment duration (3 years) and total study duration (5 years) are based on patient volume estimates provided by the Principal Investigator.

Detailed Description

To compare functional and clinical outcomes in patients with and without intact Anterior Cruciate Ligament undergoing uni-compartmental knee arthroplasty with MAKOplasty Robotic-Arm Assisted Surgery. The primary outcome measurement tools utilized will be the Knee Society Score (KSS) and Knee Injury and Osteoarthritis Outcomes Score (KOOS,JR). Both the Knee Society Score and Knee Injury and Osteoarthritis Outcomes Score (KOOS,JR) are validated scoring systems. Patient-reported outcome data will be collected at the following study time points:

• Preoperatively - Knee Society Score: Pre-Op, Knee Injury and Osteoarthritis Outcomes Score
• 3 weeks (±1 week) - Knee Society Score: Post-Operative, Knee Injury and Osteoarthritis Outcomes Score , Subject Global Satisfaction Survey
• 6 weeks (± 1 week) - Knee Society Score: Post-Operative, Knee Injury and Osteoarthritis Outcomes Score, Subject Global Satisfaction Survey
• 3 months (± 2 weeks) - Knee Society Score: Post-Operative, Knee Injury and Osteoarthritis Outcomes Score, Subject Global Satisfaction Survey
• 1 year (± 1 month) - Knee Society Score: Post-Operative, Knee Injury and Osteoarthritis Outcomes Score, Subject Global Satisfaction Survey
• 2 years (± 2 months) - Knee Society Score: Post-Operative, Knee Injury and Osteoarthritis Outcomes Score, Subject Global Satisfaction Survey

Subject Identification

Each subject will be assigned a unique subject number. Subject numbers will not be re-assigned or re-used for any reason. Only assigned subject numbers and associated subject age, Anterior Cruciate Ligament integrity classification, pre/intra-operative imagery information, and temporal outcome data will be shared with Sponsor. Only subjects who meet the inclusion/exclusion criteria and sign the Inform Consent Form will be assigned a unique study identification number.

Pre-Operative Anterior Cruciate Ligament Integrity

The structural integrity of the Anterior Cruciate Ligament will be determined clinically and pre-operatively with the following:

1. Lachman's anterior drawer test: Performed while the patient is in the supine position with the knee in 20° of flexion. The distal femur is fixed with one hand, while the other hand holds the proximal tibia with the thumb on the anteromedial joint line. The tibia is pulled ventrally, and the examiner estimates the ventral displacement of the tibia with respect to the femur. There are three possible outcomes: graded as 1+ (0-5 mm of displacement), 2+ (6-10 mm of displacement) or 3+ (greater than 10 mm of displacement) A 2+ or 3+ Lachman's test grade will be indicative of ACL instability.

2. Anterior drawer test: Performed with the patient in the supine position with the hips flexed to 45°, the knees flexed to 90° and the feet flat on the table. The thumbs are placed along the joint line on either side of the patellar tendon and the tibia is drawn forward anteriorly. An increased amount of anterior tibial translation compared with the opposite limb or lack of a firm end point may be indicative of either a sprain of the anteromedial bundle or complete tear of the Anterior Cruciate Ligament. If the tibia pulls forward or backward more than normal, the test is considered positive.

3. Pivot-Shift Test: Test is performed with the patient lying in supine position with the hip passively flexed to 30°.The examiner stands lateral to the patient on the side of the knee that is being examined. The lower leg and ankle is grasped maintaining 20 degrees of internal tibial rotation. The knee is allowed to sag into complete extension. The opposite hand grasps the lateral portion of the leg at the level of the superior tibiofibular joint, increasing the force of internal rotation. While maintaining internal rotation, a valgus force is applied to the knee while it is slowly flexed. If the tibia's position on the femur reduces as the knee is flexed in the range of 30 to 40 degrees or if there is an anterior subluxation felt during extension the test is positive for instability.

4. Biodex knee laxity test: This quantitative evaluation of knee laxity will be performed in accordance with the standardized procedures utilized by the Department of Physical Therapy at Florida Orthopaedic Institute.

Plain X-Ray

Knee osteoarthritis will be diagnosed and subjectively graded by taking plain radiographs in accordance with the Principal Investigator's Standard of Care, which include a (1) weight-bearing (WB) postero-anterior (PA) view, (2) sunrise view, and (3) lateral view. Degenerative disease of the knees will be graded per the Ahlback - Grades 1-5, increasing in severity or Kellgren and Lawrence Grade 0-4, increasing in severity classification systems. The Principal Investigator also uses a subjective classification system of mild, moderate, or severe osteoarthritis, which is captured in the clinic note.

Magnetic Resonance Imaging

A standardized imaging protocol will be utilized for all Magnetic Resonance Imaging images. Specifically, a 3D-proton density non-fat suppressed fast spin echo sequence shall be used. Magnetic Resonance Imaging of the knee will be obtained prior to surgery using the parameters as requested by the Sponsor using Florida Orthopaedic Institute Siemens Aera 1.5T Magnetic Resonance Imaging scanner: TR/TE=1000/46, Flip angle=120°, repetition time=1000msec, echo time=46msec, bandwidth=97.3 Hz/pixel, matrix size= 320x300 pixels. The Sponsor has requested the use of a 3T magnet, but Florida Orthopaedic Institute currently has 1.5T magnets in their Magnetic Resonance Imaging scanners, so this request cannot be accommodated. We will perform a scan with the 1.5T magnet and share with Sponsor to confirm that the available imagery information is acceptable for their purposes.

Computed Tomography (CT) Scans

A Computed Tomography scan of the knee will be obtained prior to surgery using the standardized partial knee arthroplasty Computed Tomography scanning protocol with bone mineral density (BMD) phantom protocol as provided by the Sponsor. Sponsor will provide the phantom for use during scanning. A pre-operative Computed Tomography scan is required as the Standard of Care for robotic-arm assisted knee procedures. Each patient's Computed Tomography scan is used to create a 3D model of the patient's anatomy for accurate implant planning, bone resection and implant placement.

KOOS-JR

The abbreviated version of the Knee Injury and Osteoarthritis Outcome Score (KOOS) survey is a validated and self-reported questionnaire (7 questions) designed to measure "knee health" as it reflects aspects of pain, symptom severity, and activities of daily living (ADL) including movement or activities that are directly relevant and difficult for patients with knee Osteoarthritis.The Knee Injury- Osteoarthritis Outcomes Score-JR knee survey consists of 7 questions pertaining to knee stiffness, knee pain, and physical function. The survey will be administered to all patients at baseline, 3 weeks, 6 weeks, 3 months, 1 year and 2 years.

KSS

The knee society score has been in use for over 20 years and is a simple, objective means to measure a patient's functional ability before and after surgery (11-13). It includes ROM assessment. The Principal Investigator will utilize the updated Knee Society Score (2011), which has been modified to include both an objective physician-derived component with a subjective patient-derived component that evaluates pain relief, functional abilities, satisfaction, and fulfillment of expectations. This updated scoring system prioritizes the patient perspective, to better track patient expectations, satisfaction, and activity levels than was possible with its predecessor. Patients will complete this survey with the Principal Investigator at all study time points.

Global Satisfaction Survey

This custom, 2-page survey has been designed by the study team to track patient satisfaction after their Unicompartmental Knee Arthroplasty over time. It's a simple, seven-item survey that also includes a Visual Analogue Scale for knee pain. The survey will be administered to all patients at all post-operative visits.

Intra-Operative Anterior Cruciate Ligament Integrity

During surgery, the Anterior Cruciate Ligament will be inspected, manually stressed and probed following standard techniques to assess its structure and function.The state of the Anterior Cruciate Ligament will be recorded and classified into one of four categories per these intra-operative examinations and available pre-operative Magnetic Resonance Imaging data:

Group 1 - intact Anterior Cruciate Ligament Group 2 - intact but fibrillated (frayed) ligament) Group 3 - nearly completely torn ligament (>50% and disrupted)

Assessment will be performed by the Principal Investigator. Knees with Anterior Cruciate Ligaments classified as Group 1 and Group 2 will be accepted as functionally intact. Those classified as Group 3 will be deemed as having functionally absent Anterior Cruciate Ligaments.

Conditions

Clinical Outcomes

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Group 1

Group 1 - intact ACL ligament will be accepted as functionally intact

unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.

Group Type: ACTIVE_COMPARATOR

Unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.

Intervention Type: PROCEDURE

All patients will receive the RESTORIS MCK (Multicompartmental Knee) Implant System, which is approved for use in unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system. The femoral component is constructed from cobalt chrome (CoCr) and the tibial component is constructed from an ultra-high molecular weight polyethylene (UHMWPE) insert and titanium (Ti) baseplate. UKA will be facilitated with MAKO Robotic-Arm Assisted Surgery, which has been shown in prior studies to lower pain and result in more accurate implant placement than manual UKA in a randomized controlled trial.(15)

Group 2

Group 2 - intact but fibrillated (frayed) ligament) will be accepted as functionally intact

unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.

Group Type: ACTIVE_COMPARATOR

Unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.

Intervention Type: PROCEDURE

All patients will receive the RESTORIS MCK (Multicompartmental Knee) Implant System, which is approved for use in unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system. The femoral component is constructed from cobalt chrome (CoCr) and the tibial component is constructed from an ultra-high molecular weight polyethylene (UHMWPE) insert and titanium (Ti) baseplate. UKA will be facilitated with MAKO Robotic-Arm Assisted Surgery, which has been shown in prior studies to lower pain and result in more accurate implant placement than manual UKA in a randomized controlled trial.(15)

Group 3

Group 3 - nearly completely torn ligament (>50% and disrupted) will be deemed as having functionally absent ACLs

unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.

Group Type: ACTIVE_COMPARATOR

Unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.

Intervention Type: PROCEDURE

All patients will receive the RESTORIS MCK (Multicompartmental Knee) Implant System, which is approved for use in unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system. The femoral component is constructed from cobalt chrome (CoCr) and the tibial component is constructed from an ultra-high molecular weight polyethylene (UHMWPE) insert and titanium (Ti) baseplate. UKA will be facilitated with MAKO Robotic-Arm Assisted Surgery, which has been shown in prior studies to lower pain and result in more accurate implant placement than manual UKA in a randomized controlled trial.(15)

Interventions

Unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.

All patients will receive the RESTORIS MCK (Multicompartmental Knee) Implant System, which is approved for use in unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system. The femoral component is constructed from cobalt chrome (CoCr) and the tibial component is constructed from an ultra-high molecular weight polyethylene (UHMWPE) insert and titanium (Ti) baseplate. UKA will be facilitated with MAKO Robotic-Arm Assisted Surgery, which has been shown in prior studies to lower pain and result in more accurate implant placement than manual UKA in a randomized controlled trial.(15)

Intervention Type: PROCEDURE

Other Intervention Names

UKA with Mako Robotic Arm-assisted system

Eligibility Criteria

Inclusion Criteria

Subjects must meet these criteria to participate in this study:

1. Patients with isolated, symptomatic femorotibial knee arthritis and candidates for UKA;

2. Patients ≥ 21 years old;

3. Patients with intact and non-functional ACLs as determined through pre-operative imaging, knee laxity tests, rotational stability tests, and intraoperative ACL classification;

4. Patients willing and able to sign an informed consent;

5. Patients willing and able to comply with 2-year follow-up commitments.

Exclusion Criteria

1. Patients with RA;

2. Patients with BMI >40;

3. Patients with ROM arc > 75°;

4. Patients with greater than 10º of hyperextension;

5. Patients with greater than 15º of varus or valgus deformity;

6. Patients with active infection;

7. Patients without sufficient bone stock to allow appropriate insertion and fixation of the prosthesis;

8. Patients without sufficient soft tissue integrity to provide adequate stability;

9. Patients with either mental or neuromuscular disorders that do not allow control of the knee joint;

10. Patients whose weight, age or activity level might cause extreme loads and early failure of the system.

• Minimum Eligible Age: 21 Years
• Maximum Eligible Age: 100 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Stryker Orthopaedics

INDUSTRY

Sponsor Role: collaborator

Foundation for Orthopaedic Research and Education

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Florida Orthopaedic Institute

Tampa, Florida, United States

Countries

United States

Other Identifiers

MM-MAKO-001

Identifier Type: -

Identifier Source: org_study_id